SCHEMBL6205740

SCHEMBL6205740

COC(=O)Oc1cn(Cc2ccccc2)nn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ CYP19A1 P11511 4/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ HDAC9 Q9UKV0 1/20 0.45
▸ HDAC5 Q9UQL6 1/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ CDC7 O00311 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27850347 0.81 CYP19A1 (0.58) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL28805659 0.78 HSP90AB1 (0.54) ALDH1A1LMNACYP19A1MEN1KMT2A
SCHEMBL1719412 0.77 ALDH1A1 (0.75) ALDH1A1LMNACYP19A1MEN1KMT2A
SCHEMBL24666587 0.75 CYP19A1 (0.57) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL11119957 0.75 TYR (0.51) ALDH1A1LMNACYP19A1HDAC1HDAC3
SCHEMBL29230705 0.74 ALDH1A1 (0.49) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL28103690 0.74 CYP19A1 (0.51) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL27958968 0.73 CYP19A1 (0.59) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL1838394 0.73 CYP19A1 (0.51) ALDH1A1LMNACYP19A1NPC1RAB9A
SCHEMBL27644462 0.72 KDM4E (0.48) ALDH1A1LMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597228-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2005-11-23 — — EP disclosed
WO-2004072025-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 — — WO disclosed
Send feedback